We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Bosch Healthcare Presents Vivalytic Point-of-Care PCR System

By LabMedica International staff writers
Posted on 13 Nov 2023

Bosch Healthcare Solutions (Waiblingen, Germany) is present at this year’s MEDICA to showcase new tests and its universal platform for molecular diagnostics at the point of care. More...

The MEDICA is an annual international trade fair for the medical industry. At the trade fair, exhibitors from all over the world present their latest products, services, and technologies in the fields of medicine, health care, and nursing. MEDICA is an important platform for the exchange of knowledge and experience between professionals in the industry, including doctors, nurses, medical technicians, and healthcare managers. In addition to the exhibition, various forums and conferences are held each year, where experts from different areas of the medical industry give presentations and lead discussions. These forums provide a great opportunity for professionals to learn about the latest trends and developments in their respective fields and to exchange ideas with other experts.

This year, for the first time and exclusively, Bosch Healthcare Solutions is organizing a panel discussion with Vivalytic, and to discuss the topic of laboratory diagnostics at the point of care with experts from various industries. Particular importance will be given to point-of-care PCR systems, such as Vivalytic, which provide rapid test results at the point of sample collection and are easy and intuitive to operate. This exclusive event will provide new insights into the "Third Pillar" of diagnostics. The panelists are proven experts in their field and will be sharing some experiential insights on the topic. Visitors can also attend the round table discussion to learn more about the innovative Vivalytic system and the challenges of the diagnostics sector at the point of care.

Related Links:
Bosch Healthcare Solutions


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.